Thirty years and counting: Where will HIV research go next?

In 5 seconds

Canadian researchers available to discuss their HIV research and the challenges and successes in the fight against the disease.

For the past three decades, Canada has been a leader in HIV/AIDS research, but there is still a lot of work to do—both at home and abroad. From July 19-22, 2015, delegates from all over the world will flock to Vancouver for the 8th International AIDS Society Conference on HIV (IAS 2015) to share their research and, in part, to hear about the successes and challenges specific to HIV (and HIV research) in Canada.


What are the newest developments in HIV/AIDS research? How are Canadian scientists contributing to the global effort to stop the epidemic? In what way is research helping improve the lives of Canadians with HIV?


  • Dr. Marc Ouellette, the Scientific Director of the CIHR Institute of Infection and Immunity, is available to discuss advances in the science of HIV infection, prevention and treatment
  • Dr. Jonathan Angel, a prominent CIHR-funded researcher at the Ottawa Hospital Research Institute, can answer questions about HIV, the immune system, and the impact of antiretroviral therapies
  • Dr. Marina Klein, a CIHR-funded expert in clinical and epidemiologic aspects of HIV and Hepatitis C co-infection, can highlight the challenges of this co-infection—such as the rapid progression of liver disease—and how research is starting to address this emerging public health issue
  • Dr. Éric A. Cohen, CIHR-funded team leader of the Canadian HIV Cure Enterprise (CanCURE) and professor at the University of Montreal's Department of microbiology, infectology and immunology, is available to discuss the complexities of finding a cure for HIV and how far the science has come (including the significant discovery that his team recently made regarding how HIV escapes the body's antiviral responses)
  • Dr. Hugo Soudeyns, CIHR-funded team leader of the Early Pediatric Initiation - Canadian Child Cure Cohort (EPIC4) study and professor at the University of Montreal's Department of microbiology, infectology and immunology, can answer questions about mother-to-child transmission during pregnancy and pediatric HIV; and
  • Ms. Andrea Langlois, Director of Community-Based Research at the Pacific AIDS Network (PAN), and Dr. Catherine Worthington, CIHR-funded researcher at the University of Victoria, can each talk about the power of community-based research and how people living with HIV in British Columbia are contributing valuable input into a number of initiatives in the province.

Source : Canadian Institutes of Health Research